Target intelligence / Profile preview

Influenza A virus hemagglutinin stem (HA stem)

Target
HA stem
Molecular classification
Viral surface glycoprotein, Class I fusion protein, Receptor
01

Overview

The Influenza A virus hemagglutinin (HA) stem is a critical component of the viral entry machinery, primarily composed of the HA2 subunit and the proximal portions of the HA1 subunit. Unlike the immunodominant globular head of the HA protein, which undergoes frequent antigenic drift, the stem region is highly conserved across various influenza A subtypes, including both Group 1 and Group 2 viruses (Ekiert et al., Science 2009). Its primary biological role is to mediate the fusion between the viral envelope and the host endosomal membrane through a dramatic pH-dependent conformational change triggered upon endocytosis (UniProt P03435). This conservation makes the HA stem a premier target for the development of universal influenza vaccines and broadly neutralizing antibodies (bnAbs). Therapeutic agents targeting this region, such as the monoclonal antibody MEDI8852 or small molecules like JNJ-4796, function by binding to a hydrophobic pocket in the stem and locking the protein in its pre-fusion state (Kallewaard et al., Cell 2016). By preventing the structural rearrangement necessary for membrane fusion, these therapies can neutralize a wide range of influenza strains, offering potential protection against both seasonal drift and pandemic shift (NIH NIAID, Universal Influenza Vaccine Research).

Other names
Hemagglutinin stalkHA stalkHA2 subunitConserved HA stem domainInfluenza HA stem region
02

Mechanism of action

Inhibition of the pH-triggered conformational change of hemagglutinin, which prevents the fusion of the viral envelope with the host endosomal membrane, thereby blocking viral entry into the host cell.

03

Biological functions

Viral entryMembrane fusionHost cell attachment
04

Disease associations

InfectionInfluenza A
05

Safety considerations

Immune imprinting (Original Antigenic Sin)Potential for viral escape mutations in the conserved regionAntibody-dependent enhancement (ADE) (theoretical risk)Low immunogenicity compared to the HA head
06

Interacting drugs

MEDI8852

6 more in the full profile.

07

Biomarkers

Anti-HA stem antibody titers (ELISA)Stem-specific IgG levelsViral load reduction

Beyond the preview

Go deeper on Influenza A virus hemagglutinin stem (HA stem).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus hemagglutinin stem (HA stem).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call